Literature DB >> 12444172

Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells.

Andrea Cerutti1, Hong Zan, Edmund C Kim, Shefali Shah, Elaine J Schattner, András Schaffer, Paolo Casali.   

Abstract

Chronic lymphocytic leukemia (CLL) results from the expansion of malignant CD5(+) B cells that usually express IgD and IgM. These leukemic cells can give rise in vivo to clonally related IgG(+) or IgA(+) elements. The requirements and modalities of this process remain elusive. Here we show that leukemic B cells from 14 of 20 CLLs contain the hallmarks of ongoing Ig class switch DNA recombination (CSR), including extrachromosomal switch circular DNAs and circle transcripts generated by direct S micro -->Sgamma, S micro -->Salpha, and S micro -->Sepsilon as well as sequential Sgamma-->Salpha and Sgamma-->Sepsilon CSR. Similar CLL B cells express transcripts for activation-induced cytidine deaminase, a critical component of the CSR machinery, and contain germline I(H)-C(H) and mature V(H)DJ(H)-C(H) transcripts encoded by multiple Cgamma, Calpha, and Cepsilon genes. Ongoing CSR occurs in only a fraction of the CLL clone, as only small proportions of CD5(+)CD19(+) cells express surface IgG or IgA and lack IgM and IgD. In vivo class-switching CLL B cells down-regulate switch circles and circle transcripts in vitro unless exposed to exogenous CD40 ligand and IL-4. In addition, CLL B cells that do not class switch in vivo activate the CSR machinery and secrete IgG, IgA, or IgE upon in vitro exposure to CD40 ligand and IL-4. These findings indicate that in CLL at least some members of the malignant clone actively differentiate in vivo along a pathway that induces CSR. They also suggest that this process is elicited by external stimuli, including CD40 ligand and IL-4, provided by bystander immune cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444172      PMCID: PMC4625981          DOI: 10.4049/jimmunol.169.11.6594

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  77 in total

1.  The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites.

Authors:  A Schaffer; A Cerutti; S Shah; H Zan; P Casali
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  IgM-producing chronic lymphocytic leukemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations.

Authors:  D G Efremov; M Ivanovski; F D Batista; G Pozzato; O R Burrone
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

3.  Circular DNA is excised by immunoglobulin class switch recombination.

Authors:  T Iwasato; A Shimizu; T Honjo; H Yamagishi
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

4.  Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease.

Authors:  H Kanzler; R Küppers; S Helmes; H H Wacker; A Chott; M L Hansmann; K Rajewsky
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

5.  Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification.

Authors:  M Dono; S Hashimoto; F Fais; V Trejo; S L Allen; S M Lichtman; P Schulman; V P Vinciguerra; B Sellars; P K Gregersen; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1996-02-15       Impact factor: 22.113

Review 6.  Germinal centers.

Authors:  I C MacLennan
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.

Authors:  Paolo Ghia; Giuliana Strola; Luisa Granziero; Massimo Geuna; Giuseppe Guida; Federica Sallusto; Nancy Ruffing; Licia Montagna; Paola Piccoli; Marco Chilosi; Federico Caligaris-Cappio
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

8.  Identification and characterization of an IkappaB kinase.

Authors:  C H Régnier; H Y Song; X Gao; D V Goeddel; Z Cao; M Rothe
Journal:  Cell       Date:  1997-07-25       Impact factor: 41.582

9.  AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line.

Authors:  Ahmad Faili; Said Aoufouchi; Quentin Guéranger; Carole Zober; Anne Léon; Barbara Bertocci; Jean-Claude Weill; Claude-Agnès Reynaud
Journal:  Nat Immunol       Date:  2002-07-29       Impact factor: 25.606

10.  Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development.

Authors:  E J Messika; P S Lu; Y J Sung; T Yao; J T Chi; Y H Chien; M M Davis
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

View more
  15 in total

1.  Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.

Authors:  Montserrat Cols; Carolina M Barra; Bing He; Irene Puga; Weifeng Xu; April Chiu; Wayne Tam; Daniel M Knowles; Stacey R Dillon; John P Leonard; Richard R Furman; Kang Chen; Andrea Cerutti
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

2.  Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification.

Authors:  Alicia D Volkheimer; J Brice Weinberg; Bethany E Beasley; John F Whitesides; Jon P Gockerman; Joseph O Moore; Garnett Kelsoe; Barbara K Goodman; Marc C Levesque
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

3.  Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice.

Authors:  Ai Kotani; Naoki Kakazu; Tatsuaki Tsuruyama; Il-mi Okazaki; Masamichi Muramatsu; Kazuo Kinoshita; Hitoshi Nagaoka; Daisuke Yabe; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-24       Impact factor: 11.205

Review 4.  The regulation of IgA class switching.

Authors:  Andrea Cerutti
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

5.  AID expression increased by TNF-α is associated with class switch recombination of Igα gene in cancers.

Authors:  Zhi Duan; Hui Zheng; Haidan Liu; Ming Li; Min Tang; Xinxian Weng; Wei Yi; Ann M Bode; Ya Cao
Journal:  Cell Mol Immunol       Date:  2015-04-06       Impact factor: 11.530

6.  Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF.

Authors:  Weifeng Xu; Paul A Santini; Allysia J Matthews; April Chiu; Alessandro Plebani; Bing He; Kang Chen; Andrea Cerutti
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

7.  IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions.

Authors:  Piers E M Patten; Charles C Chu; Emilia Albesiano; Rajendra N Damle; Xiao-Jie Yan; Dorothy Kim; Lu Zhang; Amanda R Magli; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Sergio Roa; Patricia K Mongini; Thomas MacCarthy; Matthew D Scharff; Nicholas Chiorazzi
Journal:  Blood       Date:  2012-10-15       Impact factor: 22.113

8.  Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.

Authors:  Frances Humby; Michele Bombardieri; Antonio Manzo; Stephen Kelly; Mark C Blades; Bruce Kirkham; Jo Spencer; Costantino Pitzalis
Journal:  PLoS Med       Date:  2009-01-13       Impact factor: 11.069

Review 9.  Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.

Authors:  Michele Dal-Bo; Francesco Bertoni; Francesco Forconi; Antonella Zucchetto; Riccardo Bomben; Roberto Marasca; Silvia Deaglio; Luca Laurenti; Dimitar G Efremov; Gianluca Gaidano; Giovanni Del Poeta; Valter Gattei
Journal:  J Transl Med       Date:  2009-08-28       Impact factor: 5.531

10.  IL4 gene polymorphism and previous malaria experiences manipulate anti-Plasmodium falciparum antibody isotype profiles in complicated and uncomplicated malaria.

Authors:  Piyatida Tangteerawatana; Hedvig Perlmann; Masashi Hayano; Thareerat Kalambaheti; Marita Troye-Blomberg; Srisin Khusmith
Journal:  Malar J       Date:  2009-12-10       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.